• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良故事记忆技巧在进展性多发性硬化症中的疗效。

The efficacy of the modified Story Memory Technique in progressive MS.

机构信息

Neuropsychology and Neuroscience Laboratory, Kessler Foundation, West Orange, NJ, USA; Department of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA; Neuropsychology and Neuroscience Laboratory, Kessler Foundation, East Hanover, NJ, USA.

Neuropsychology and Neuroscience Laboratory, Kessler Foundation, West Orange, NJ, USA.

出版信息

Mult Scler. 2020 Mar;26(3):354-362. doi: 10.1177/1352458519826463. Epub 2019 Feb 11.

DOI:10.1177/1352458519826463
PMID:30741103
Abstract

BACKGROUND

Impairments in new learning and memory are common in individuals with multiple sclerosis (MS), negatively impacting everyday life, including occupational and social functioning.

OBJECTIVE

This study examined the efficacy of the modified Story Memory Technique (mSMT) in a progressive multiple sclerosis (PMS) sample through a double-blind, placebo-controlled, randomized clinical trial (RCT).

METHODS

Thirty (30) individuals with PMS, naïve to the mSMT, were randomized to the treatment or placebo control group. completed mSMT training twice per week for 5 weeks while the met with the therapist at the same frequency, engaging in non-training-oriented tasks to control for professional contact and disease alterations.

RESULTS

The treatment group showed significant improvements in learning compared with the placebo control group, evident on both objective evaluation of new learning and self-report of functioning in daily life. Increased awareness of cognitive deficits was also noted post-treatment.

CONCLUSION

These data provide Class I evidence supporting the efficacy of the mSMT in PMS. A behavioral intervention, targeted to specifically strengthen new learning, can significantly improve memory performance in PMS, and this improvement in memory performance is maintained 3 months later.

摘要

背景

新学习和记忆损伤在多发性硬化症(MS)患者中很常见,对日常生活产生负面影响,包括职业和社交功能。

目的

本研究通过一项双盲、安慰剂对照、随机临床试验(RCT),检查改良故事记忆技术(mSMT)在进展性多发性硬化症(PMS)患者中的疗效。

方法

30 名 PMS 患者(对 mSMT 不了解)随机分为治疗组或安慰剂对照组。治疗组每周接受 2 次 mSMT 训练,共 5 周,而对照组则在相同频率与治疗师会面,进行非训练导向的任务,以控制专业接触和疾病变化。

结果

与安慰剂对照组相比,治疗组在新学习方面表现出显著改善,客观评估新学习和日常生活功能的自我报告均显示出这种改善。治疗后还注意到认知缺陷的意识增加。

结论

这些数据提供了 I 级证据,支持 mSMT 在 PMS 中的疗效。针对新学习的行为干预可以显著改善 PMS 患者的记忆表现,并且这种记忆表现的改善在 3 个月后仍能维持。

相似文献

1
The efficacy of the modified Story Memory Technique in progressive MS.改良故事记忆技巧在进展性多发性硬化症中的疗效。
Mult Scler. 2020 Mar;26(3):354-362. doi: 10.1177/1352458519826463. Epub 2019 Feb 11.
2
Efficacy of the Spanish modified Story Memory Technique in Mexicans with multiple sclerosis: A pilot randomized controlled trial.西班牙改良故事记忆技术对多发性硬化症墨西哥患者的疗效:一项初步随机对照试验。
NeuroRehabilitation. 2019;45(3):349-358. doi: 10.3233/NRE-192808.
3
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.一项治疗多发性硬化学习障碍的 RCT:MEMREHAB 试验。
Neurology. 2013 Dec 10;81(24):2066-72. doi: 10.1212/01.wnl.0000437295.97946.a8. Epub 2013 Nov 8.
4
Examining the Efficacy of the Modified Story Memory Technique (mSMT) in Persons With TBI Using Functional Magnetic Resonance Imaging (fMRI): The TBI-MEM Trial.使用功能磁共振成像(fMRI)研究改良故事记忆技术(mSMT)对创伤性脑损伤(TBI)患者的疗效:TBI-MEM试验。
J Head Trauma Rehabil. 2015 Jul-Aug;30(4):261-9. doi: 10.1097/HTR.0000000000000164.
5
An RCT to Treat Learning Impairment in Traumatic Brain Injury: The TBI-MEM Trial.一项治疗创伤性脑损伤学习障碍的随机对照试验:TBI-MEM试验。
Neurorehabil Neural Repair. 2016 Jul;30(6):539-50. doi: 10.1177/1545968315604395. Epub 2015 Sep 10.
6
Increased cerebral activation after behavioral treatment for memory deficits in MS.多发性硬化症记忆缺陷的行为治疗后大脑激活增加。
J Neurol. 2012 Jul;259(7):1337-46. doi: 10.1007/s00415-011-6353-x. Epub 2012 Jan 12.
7
The influence of cognitive dysfunction on benefit from learning and memory rehabilitation in MS: A sub-analysis of the MEMREHAB trial.认知功能障碍对多发性硬化症患者从学习与记忆康复中获益的影响:MEMREHAB试验的一项亚分析
Mult Scler. 2015 Oct;21(12):1575-82. doi: 10.1177/1352458514567726. Epub 2015 Feb 6.
8
Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.以目标为导向的认知康复治疗早期阿尔茨海默病及相关痴呆: GREAT RCT 研究。
Health Technol Assess. 2019 Mar;23(10):1-242. doi: 10.3310/hta23100.
9
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.大剂量辛伐他汀对继发进展型多发性硬化症认知、神经精神及健康相关生活质量指标的影响:MS-STAT随机、安慰剂对照试验的二次分析
Lancet Neurol. 2017 Aug;16(8):591-600. doi: 10.1016/S1474-4422(17)30113-8. Epub 2017 Jun 7.
10
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.一项关于 mSMT 治疗后工作记忆任务中大脑功能活动变化的初步研究:MEMREHAB 试验。
Mult Scler Relat Disord. 2016 May;7:76-82. doi: 10.1016/j.msard.2016.03.012. Epub 2016 Mar 24.

引用本文的文献

1
Hypoxic Neuroinflammation in the Pathogenesis of Multiple Sclerosis.缺氧性神经炎症在多发性硬化症发病机制中的作用
Brain Sci. 2025 Feb 26;15(3):248. doi: 10.3390/brainsci15030248.
2
Non-Pharmacological Treatments of Cognitive Impairment in Multiple Sclerosis: A Review.多发性硬化症认知障碍的非药物治疗:综述
NeuroSci. 2022 Aug 22;3(3):476-493. doi: 10.3390/neurosci3030034. eCollection 2022 Sep.
3
The refined Pathways to Cures Research Roadmap for multiple sclerosis cures.多发性硬化症治愈的精细化途径研究路线图。
Mult Scler. 2024 Sep;30(10):1242-1251. doi: 10.1177/13524585241266483. Epub 2024 Aug 30.
4
Cognitive telerehabilitation: an expert consensus paper on current evidence and future perspective.认知远程康复:关于当前证据和未来展望的专家共识文件。
Front Neurol. 2024 Feb 15;15:1338873. doi: 10.3389/fneur.2024.1338873. eCollection 2024.
5
Assessment and Management of Cognitive and Psychosocial Difficulties for People with Multiple Sclerosis in Ireland: A National Survey of Clinical Practice.爱尔兰多发性硬化症患者认知和心理社会困难的评估和管理:临床实践的全国性调查。
Int J Clin Pract. 2022 Oct 21;2022:3232076. doi: 10.1155/2022/3232076. eCollection 2022.
6
Cognitive Rehabilitation in Multiple Sclerosis in the Period from 2013 and 2021: A Narrative Review.2013年至2021年期间多发性硬化症的认知康复:一项叙述性综述
Brain Sci. 2021 Dec 30;12(1):55. doi: 10.3390/brainsci12010055.
7
Memory rehabilitation for people with multiple sclerosis.多发性硬化症患者的记忆康复。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD008754. doi: 10.1002/14651858.CD008754.pub4.
8
Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance.优先推进多发性硬化症康复研究:国际多发性硬化症进展联盟的呼吁。
Mult Scler. 2021 Jun;27(7):989-1001. doi: 10.1177/1352458521999970. Epub 2021 Mar 15.
9
Focus on neglected features of cognitive rehabilitation in MS: Setting and mode of the treatment.关注 MS 认知康复中被忽视的特征:治疗的设置和模式。
Mult Scler. 2022 Jun;28(7):1009-1019. doi: 10.1177/1352458520966300. Epub 2020 Oct 13.
10
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.多发性硬化症的认知障碍:临床管理、MRI 和治疗途径。
Lancet Neurol. 2020 Oct;19(10):860-871. doi: 10.1016/S1474-4422(20)30277-5. Epub 2020 Sep 16.